Skip to main content


A recent systematic review investigated the effectiveness of capecitabine for the prevention of precancerous and cancerous skin lesions, including squamous cell carcinoma.
Findings from a recent study showed patients with hidradenitis suppurativa experienced significant delays in receiving a diagnosis, and these delays were associated with more severe disease burden.
A recent pooled analysis of two phase 3 randomized clinical trials showed a new once-daily lotion formulation was safe, effective, and well-tolerated among pediatric patients with moderate to severe acne.
Findings from two European studies published in JAMA Dermatology assessed the potential association between chilblains and COVID-2019.
Findings from two large cohort studies highlighted the potential association between atopic dermatitis (AD), overall and specific cancer risks, and the influence of AD severity on this risk.
Findings from a recent systematic review and meta-analysis showed an association between the development of bullous pemphigoid and the use of several medications.
A recent poster study, presented at AAD VMX 2020, showed that adalimumab effectively reduced hidradenitis suppurativa activity among patients at an outpatient dermatology center.
A recent study demonstrated the safety and long-term effectiveness of bimekizumab, with participants maintaining high PASI scores through 60 weeks of treatment.
Back to Top